As of 2025-04-22, the Intrinsic Value of ProMIS Neurosciences Inc (PMN.TO) is -25.46 CAD. This PMN.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.00 CAD, the upside of ProMIS Neurosciences Inc is -524.41%.
Based on its market price of 6.00 CAD and our intrinsic valuation, ProMIS Neurosciences Inc (PMN.TO) is overvalued by 524.41%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -25.46 - -25.46 | -25.46 | -524.41% |
| P/E | (2.44) - (8.86) | (3.06) | -150.9% |
| DDM - Stable | (53.02) - (215.39) | (134.21) | -2336.8% |
| DDM - Multi | (27.49) - (88.11) | (42.06) | -800.9% |
| Market Cap (mil) | 24.65 |
| Beta | 0.71 |
| Outstanding shares (mil) | 4.11 |
| Enterprise Value (mil) | 21.32 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.43% |
| Cost of Debt | 5.00% |
| WACC | 6.06% |